Boosting leukemia-specific T cell responses in patients following stem cell transplantation

Whole tumor cell-based vaccines administered within the first 2 to 3 months after allogeneic stem cell transplantation stand out as a promising approach to enhance graft-vs.-leukemia responses. Herein, the implications of this finding for the development of strategies to improve the outcome of patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Burkhardt, Ute E, Wu, Catherine J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2013
Materias:
Author's View
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897523/
https://www.ncbi.nlm.nih.gov/pubmed/24482749
http://dx.doi.org/10.4161/onci.26587

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897523/
https://www.ncbi.nlm.nih.gov/pubmed/24482749
http://dx.doi.org/10.4161/onci.26587

Ejemplares similares